The Vector and Cell Processing Core (VCPC) was established as part of the Division of Gene Therapy and Regenerative Medicine (GTRM) at the WaNPRC.

The VCPC offers vector-based gene therapy resources for a range of nonhuman primate studies. This core also develops new technologies, platforms and reagents to improve vector production and modification of diverse nonhuman primate cell types.

VCPC provides:

  • Viral vectors
  • Viral titer assessment
  • Pre-validated control vectors and assays to detect virus replication
  • Ready-to-use nonhuman primate cells
  • Gene-modified cell products for T cell and stem cell applications